Characteristics of Blood- Brain Barrier Permeability in Neurological Patients
Blood- Brain Barrier Permeability in Neurological Patients: Anatomical, Neurophysiological, and Clinical Characteristics
1 other identifier
observational
100
1 country
1
Brief Summary
The main goal of the present study is to challenge the hypothesis that blood- brain barrier disruption following brain injury increases the risk for long-term disability, development of brain dysfunction, epileptic seizures and neuroanatomical alterations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2007
CompletedFirst Posted
Study publicly available on registry
January 9, 2007
CompletedJanuary 9, 2007
November 1, 2006
January 7, 2007
January 7, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- One week following:
- Traumatic Brain Injury
- Cerebro- Vascular Accident
- Subsequent brain CT showed cerebral cortex injury.
You may not qualify if:
- A known ailment of the central nervous system.
- Use of medications or illicit drugs that significantly affect the central nervous system.
- tourist or temporary residents not available for follow-up.
- For MRI examinations: heart pacemaker, metal implants, or metal shrapnel.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Soroka University Medical Center
Beersheba, Israel
Related Publications (4)
Tomkins O, Friedman O, Ivens S, Reiffurth C, Major S, Dreier JP, Heinemann U, Friedman A. Blood-brain barrier disruption results in delayed functional and structural alterations in the rat neocortex. Neurobiol Dis. 2007 Feb;25(2):367-77. doi: 10.1016/j.nbd.2006.10.006. Epub 2006 Dec 22.
PMID: 17188501BACKGROUNDIvens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain. 2007 Feb;130(Pt 2):535-47. doi: 10.1093/brain/awl317. Epub 2006 Nov 21.
PMID: 17121744BACKGROUNDDreier JP, Jurkat-Rott K, Petzold GC, Tomkins O, Klingebiel R, Kopp UA, Lehmann-Horn F, Friedman A, Dichgans M. Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology. 2005 Jun 28;64(12):2145-7. doi: 10.1212/01.WNL.0000176298.63840.99.
PMID: 15985592BACKGROUNDSeiffert E, Dreier JP, Ivens S, Bechmann I, Tomkins O, Heinemann U, Friedman A. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci. 2004 Sep 8;24(36):7829-36. doi: 10.1523/JNEUROSCI.1751-04.2004.
PMID: 15356194BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alon Friedman, MD/PhD
Soroka University Medical Center
- PRINCIPAL INVESTIGATOR
Ilan Shelef, MD
Soroka University Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 7, 2007
First Posted
January 9, 2007
Last Updated
January 9, 2007
Record last verified: 2006-11